Prognosis and Treatment of Gastric Cancer: A 2024 Update

Abstract

Due to the high death rate associated with gastric cancer, a great deal of research has been conducted on this disease. The goal of this paper was to start a trimestral review of 2024 for the year that had just started. The scientific literature from 1 January 2024 was chosen with consideration of the the guidelines of the European Society of Medical Oncology (ESMO), which are updated with new findings but not systematically reviewed annually. We used the search term “gastric cancer” to find the most current publications in the PubMed database related to the prognosis and treatment of gastric cancer. As previously said, the only articles that satisfied the inclusion criteria were those from 2024. Articles with case reports were eliminated since they had nothing to do with our research. The treatment of gastric cancer is the focus of the majority of articles from 2024. The primary research axes include surgery and immunonutrition, immunotherapy and Helicobacter pylori, and therapeutic targets. Patients with GC may experience less psychological, social, and financial hardship if the recently identified markers discovered in circulation are better assessed and validated. This could be achieved by either including the markers in an artificial intelligence-based diagnostic score or by using them in conjunction with traditional diagnostic methods. Due to the rising death rate associated with GC, funding for research into diagnosis, prognosis, therapy, and therapeutic targets is essential.

Helicobacter pylori Infection in Patients with Gastric Cancer: A 2024 Update

“…To determine the presence of H. pylori infection, more sensitive and thorough diagnostic techniques must be used, and any other variables that can affect the course of treatment must be carefully considered. Consequently, a more complex understanding of the relationship between GC and H. pylori infection is required [ 12 , 13 ]. This review aims to provide an update on the major developments in the study of H. pylori and GC in recent years.…”

Predictive Factors of Immunotherapy in Gastric Cancer: A 2024 Update

“…The underlying mechanisms of the immune response are incredibly intricate and poorly understood. In GC, there are legitimate expectations for the development of secure and more efficient immunotherapies [ 1 , 2 ]. Patients with GC may survive longer because of immunotherapy.…”

Micro gas chromatography column using ionic liquid modified metal-organic framework as stationary phase for rapid breath analysis of gastric cancer

“…Gastric cancer is the fourth most common cancer in the world, with approximately 1.03 million deaths in 2022 [1][2][3][4]. It remains difficult for gastric cancer patients to be effectively cured because most of them find the cancer at an advanced stage [5].…”